选择性向Plasmodium falciparum Hsp90用于疟疾的可能性和挑战

Thato Matlhodi1, Lisema Patrick Makatsela1, Njabulo Joyfull Gumede2

  • 1Department of Biochemistry, Faculty of Natural and Agricultural Science, North-West University, Mmabatho, South Africa.

Transactions of the Royal Society of South Africa. Royal Society of South Africa
|March 16, 2026
PubMed
概括

开发针对Plasmodium falciparum热冲击蛋白90 (PfHsp90) 异型的新型疟疾药物显示出有希望. 结构性比较和先进的药物发现方法是克服选择性挑战和创造有效抗疟疾药物的关键.